C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2004
11/02/2004	US6812327 Neutrokine-alpha polypeptides
11/02/2004	US6812326 Tumor necrosis factor receptor-associated factor (traf) protein-interacting hereditary multiple extoses (trex) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents
11/02/2004	US6812224 Phosphorous organic compounds and their use
11/02/2004	US6812221 Immobilization
11/02/2004	US6812210 Urocortin-III and uses thereof
11/02/2004	US6812207 Hemoglobin mutants that reduce heme loss
11/02/2004	US6812206 Contacting body fluid from mammal with antibody which binds to human aspartyl (asparaginyl) beta-hydroxylase (haah) polypeptide under conditions sufficient to form antigen-antibody complex and detecting complex
11/02/2004	US6812203 Treatment of cd40 and/or nf-kb related diseases, antiinflammatory, antitumor
11/02/2004	US6812026 Antibodies directed against binding-associated epitopes
11/02/2004	US6812021 Isolated from streptococcus; for preparation of therapeutics (vaccines) to immunize against microbial infection; urinary tract infections; drug screening
11/02/2004	US6812006 Polynucleotide coding polypeptide for use in generation of lysine; for use in animal nutrient and human medicines
11/02/2004	US6812004 For controlling development and differentiation of mammalian cells; proteins/mimetics/antibodies; hematopoiesis
11/02/2004	US6812003 Compounds and methods for modulating cell-adhesion mediated drug resistance
11/02/2004	US6812002 Stimulating and modulating bone cell differentiation and bone formation; bone disorders including osteopetrosis and osteoporosis; genetic engineeing; gene therapy;
11/02/2004	US6811989 Pancreatic islet cell antigens obtained by molecular cloning
11/02/2004	US6811988 Compositions and methods for diagnosing Alzheimer's disease
11/02/2004	US6811987 For treating tumors, hemopathy, hiv infection, immunological disease, inflammation; drug screening; genetic engineering
11/02/2004	US6811984 Nucleotide sequences for detection of Bacillus anthracis
11/02/2004	US6811972 For preparing a hybridoma cell line which specifically recognizes and binds tumor associated antigen; antibodies; prostate carcinoma tumor antigen gene-1
11/02/2004	US6811970 Measurement of dimerization of viral polymerase; obtain sample containing viral dimerized proteins, incubate with binding agent, determine the amount of complex formed
11/02/2004	US6811787 Over-expressing homologous antigen vaccine and a method of making the same
11/02/2004	US6811785 Multivalent MHC class II—peptide chimeras
11/02/2004	US6811781 Composition and method for diagnosing auto-immune hepatitis
11/02/2004	US6811779 Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
11/02/2004	US6811774 Defective recombinant adenoviruses expressing cytokines for antitumor treatment
11/02/2004	US6811773 Human monocyte colony inhibitory factor (M-CIF) polypeptides
11/02/2004	CA2364251C Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
11/02/2004	CA2277554C Streptokinase mutants
11/02/2004	CA2168934C A brassica sp. gene promoter highly expressed during tapetum development
11/02/2004	CA2111100C Interleukin-1 beta protease and interleukin-1 beta protease inhibitors
11/02/2004	CA2096911C Amyloid precursor protein protease
10/2004
10/28/2004	WO2004092738A2 Assay for modulators of e2f-1 phosphorylation
10/28/2004	WO2004092724A2 Multiple antigenic peptide assay for detection of hiv or siv type retroviruses
10/28/2004	WO2004092405A2 Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof
10/28/2004	WO2004092398A2 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress
10/28/2004	WO2004092397A2 Tmprss2 regulatory sequences and uses thereof
10/28/2004	WO2004092386A2 Inducing a t cell response with recombinant pestivirus replicons or recombinant pestivirus replicon-transfected dendritic cells
10/28/2004	WO2004092385A1 METHOD OF DETECTING β3 ADRENALINE RECEPTOR MUTANT GENE AND NUCLEIC ACID PROBE AND KIT THEREFOR
10/28/2004	WO2004092384A2 Means and methods for diagnosing and treating affective disorders
10/28/2004	WO2004092377A1 Novel functional peptide nucleic acid and process for producing the same
10/28/2004	WO2004092373A1 Peptide having htlv-1-specific ctl-inducing activity
10/28/2004	WO2004092370A1 Protein capable of binding plasticizer
10/28/2004	WO2004092360A2 The severe acute respiratory syndrome coronavirus
10/28/2004	WO2004092356A2 Method for obtaining mastocyte lines from porcine tissue and method for production of heparin type molecules
10/28/2004	WO2004092355A1 Expression of proteins in cord blood-derived endothelial cells
10/28/2004	WO2004092350A2 G-protein coupled receptors
10/28/2004	WO2004092343A2 Epha2, hypoproliferative cell disorders and epithelial and endothelial reconstitution
10/28/2004	WO2004092338A2 Compositions, splice variants and methods relating to cancer specific genes and proteins
10/28/2004	WO2004092337A2 Promoting cardiac cell differentiation
10/28/2004	WO2004092336A2 Fragments of fluorescent proteins for protein fragment complementation assays
10/28/2004	WO2004092332A2 Sars virus polypeptides
10/28/2004	WO2004092328A2 Novel beta-tubulin protein of candida glabrata and methods for its use
10/28/2004	WO2004092221A1 Immunogen, composition for immunological use and process for producing antibody using the same
10/28/2004	WO2004092218A1 Process for producing recombinant antithrombin
10/28/2004	WO2004092217A1 Crystal structure of vegfrkd: ligand complexes and methods of use thereof
10/28/2004	WO2004092216A1 Carcinoembryonic antigen (cea) lacking a signal peptide, nucleic acid encoding it and fusion of cea with a t cell epitope and their use for the treatment and/or prophylaxis of cancer
10/28/2004	WO2004092215A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
10/28/2004	WO2004092214A2 Affinity purification system using troponin molecules as affinity ligands
10/28/2004	WO2004092213A1 Gene expressed in prostate cancer, methods and use thereof
10/28/2004	WO2004092212A2 Tumor antigens bfa5 for prevention and/or treatment of cancer
10/28/2004	WO2004092211A1 Non-fluorescent report protein activateable by proteolyse for fluorescence and the use thereof for detecting protease-depending events
10/28/2004	WO2004092210A2 Molecules having immunomodulatory activity
10/28/2004	WO2004092209A2 S. pneumoniae antigens
10/28/2004	WO2004092208A2 Sars-related proteins
10/28/2004	WO2004092207A2 Respiratory syncytial virus (rsv) peptides
10/28/2004	WO2004092206A1 Novel peptide, immunopotentiator and functional food and process for producing functional food
10/28/2004	WO2004092202A1 Process for production of cyclic peptides
10/28/2004	WO2004092201A2 Enhanced hiv-1 vaccines and methods for their use
10/28/2004	WO2004092199A2 Method for identifying modulators of g protein coupled receptor signaling
10/28/2004	WO2004092197A2 Amyloid-specific peptides and uses thereof
10/28/2004	WO2004092194A2 Chimeric polypeptides and their use
10/28/2004	WO2004092051A2 Organic polymeric material an method for the production thereof
10/28/2004	WO2004091651A1 Prongf as a pharmaceutically active agent for treating demyelinating diseases
10/28/2004	WO2004091650A1 Application of cardiac troponin i in preparing antitumour medicaments
10/28/2004	WO2004091647A1 Compositions of active wnt protein
10/28/2004	WO2004091534A2 Inhibitors of n ethylmaleimide sensitive factor
10/28/2004	WO2004091517A2 Conjugates comprising human il-18 and substitution mutants thereof
10/28/2004	WO2004091492A2 Computer-based model for identification and characterization of non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors
10/28/2004	WO2004091491A2 Profiling conformational variants, antibody compositions and methods of using the same
10/28/2004	WO2004091490A2 Somatostatin-dopamine chimeric analogs
10/28/2004	WO2004091438A2 Improved ophthalmic and contact lens solutions containing peptides as representative enhancers
10/28/2004	WO2004091436A2 Methods and compositions for treating ocular disease
10/28/2004	WO2004081200A3 Phospholipid scramblase 3
10/28/2004	WO2004078982A3 Modified low molecular weight glutenin with reduced risk to patients with celiak disease
10/28/2004	WO2004073738A3 Composition to be administered to a living being and method for marking agents
10/28/2004	WO2004067023A3 Survivin-derived peptides and use thereof
10/28/2004	WO2004065938A3 Human osteoporosis gene
10/28/2004	WO2004061456A3 Uses of hmgb, hmgn, hmga proteins
10/28/2004	WO2004058813A3 Peptides having a high cysteine content
10/28/2004	WO2004058806A3 Inclusion bodies as antigens for the oral vaccination of animals against csfv
10/28/2004	WO2004058798A9 Antimicrobial peptides
10/28/2004	WO2004056857A3 Use of the multifunctional transcription factor yin-yang-1 and variants thereof for treating illnesses, especially type 1 diabetes
10/28/2004	WO2004055041A3 Defensin-inducing peptides from fusobacterium
10/28/2004	WO2004053057A3 Gene expression systems and recombinant cell lines
10/28/2004	WO2004052929A3 Recombinant cell line
10/28/2004	WO2004052922A3 Peptides, antibodies thereto, and their use in the treatment of central nervous system damage
10/28/2004	WO2004051269A3 Ciz1 replication protein
10/28/2004	WO2004045520A3 Complement receptor 2 targeted complement modulators
10/28/2004	WO2004041858A3 Improving growth characteristics of filamentous microorganisms
10/28/2004	WO2004041857A3 Mutant of clostridium difficile toxin b and methods of use

1 ... 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 ... 2916